People | May 13, 2026
CII elects R Mukundan as President for 2026-27, Suchitra K Ella named President-Designate
Shashwat Goenka takes over as Vice President of industry body
Shashwat Goenka takes over as Vice President of industry body
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
Ajax's lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with first proof-of-concept clinical data to be presented later in 2026
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
The solution integrates key molecular cloning methods—including Golden Gate, Gibson assembly, and restriction/ligation—alongside primer design, Sanger sequencing analysis, and protein translation in a single application
Subscribe To Our Newsletter & Stay Updated
